<DOC>
	<DOCNO>NCT01084161</DOCNO>
	<brief_summary>To determine analgesic efficacy , duration effect , safety single dos N1539 subject undergo open abdominal hysterectomy</brief_summary>
	<brief_title>Study Evaluate Efficacy , Safety Tolerability N1539</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<criteria>moderate severe pain VAS &gt; /= 45 mm undergo open abdominal hysterectomy ASA I II sign ICF BMI &gt; 18.5 &lt; 31.5 kg/m^2 suspect metastatic cervical endometrial cancer prior abdominal surgery postoperative complication active pancreatitis , obstruction biliary tree total bilirubin &gt; 2.5 mg/dL active GI bleeding , peptic ulcer disease unstable medical condition HbA1c &gt; 9.5 uncontrolled diabetes SBP &gt; 150 mmHg DBP &gt; 95 mmHg personal familial contraindication undergo general anesthesia Antihypertensive agent diabetic regimen stable ( 4 week prior surgery ) take CNS agent pain acetaminophen NSAIDs discontinue least 5 halflives prior plan surgery currently take opioid take opioid chronically pain past 2 year corticosteroid systemic corticosteroid within 6 week plan surgery know bleed disorder take agent affect coagulation history intolerance allergic reaction NSAIDs , COX2 inhibitor , aspirin salicylate receive lithium combination furosemide ACE inhibitor angiotensin receptor blocker Known sleep apnea History hepatitis B C AST ALT &gt; 2 time upper limit normal Known suspect COPD retention carbon dioxide psychiatric condition impairs capability subject report pain</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>